Vulvovaginal graft-versus-host disease: a review

References

• Yoshimi A, Baldomero H, Horowitz M, et al. Global use of peripheral blood vs bone marrow as source of stem cells for allogeneic transplantation in patients with bone marrow failure. JAMA 2016;315:198–200
   PubMed Web of Science ®Google Scholar
• D’Souza A, Lee S, Zhu X, et al. Current use and trends in hematopoietic cell transplantation in the United States. Biol Blood Marrow Transplant 2017;23:1417–21
   PubMed Web of Science ®Google Scholar
• Majhail NS, Farnia SH, Carpenter PA, et al. Indications for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2015;21:1863–9
   PubMed Web of Science ®Google Scholar
• Hołowiecki J. Indications for hematopoietic stem cell transplantation. Pol Arch Med Wewn 2008;118:658–63
   PubMedGoogle Scholar
• Milroy CL, Jones KP. Gynecologic care in hematopoietic stem cell transplant patients: a review. Obstet Gynecol Surv 2010;65:668–79
   PubMed Web of Science ®Google Scholar
• Ferrara JLM, Levine JE, Reddy P, et al. Graft-vs.-host disease. Lancet 2009;373:1550–61
   PubMed Web of Science ®Google Scholar
• Lee SJ. Classification systems for chronic graft-vs.-host disease. Blood 2017;129:30–7
   PubMed Web of Science ®Google Scholar
• Aki SZ, Inamoto Y, Carpenter PA, et al. Confounding factors affecting the National Institutes of Health (NIH) chronic graft-vs.-host disease organ-specific score and global severity. Bone Marrow Transplant 2016;51:1350–3
   PubMed Web of Science ®Google Scholar
• Smith Knutsson E, Björk Y, Broman A-K, et al. Genital chronic graft-vs.-host disease in females: a cross-sectional study. Biol Blood Marrow Transplant 2014;20:806–11
   PubMed Web of Science ®Google Scholar
• Smith Knutsson E, Björk Y, Broman A-K, et al. A prospective study of female genital chronic graft-vs.-host disease symptoms, signs, diagnosis and treatment. Acta Obstet Gynecol Scand 2018;97:1122–9
   PubMed Web of Science ®Google Scholar
• Van Dam N, Zelker R, Radiano R, et al. Vulvar and vaginal graft vs. host disease: a healthcare clinic initiative. Asia Pac J Oncol Nurs 2017;4:116–19
   PubMed Web of Science ®Google Scholar
• Corson SL, Sullivan K, Batzer F, et al. Gynecologic manifestations of chronic graft-vs.-host disease. Obstet Gynecol 1982;60:488–92
   PubMed Web of Science ®Google Scholar
• Ciavattini A, Clemente N. Female genital tract chronic graft-vs.-host disease: review of the literature. Anticancer Res 2015;35:13–17
   PubMed Web of Science ®Google Scholar
• Hirsch P, Leclerc M, Rybojad M, et al. Female genital chronic graft-vs.-host disease: importance of early diagnosis to avoid severe complications. Transplantation 2012;93:1265–9
   PubMed Web of Science ®Google Scholar
• Zantomio D, Grigg AP, MacGregor L, et al. Female genital tract graft-vs.-host disease: incidence, risk factors and recommendations for management. Bone Marrow Transplant 2006;38:567–72
   PubMed Web of Science ®Google Scholar
• Spinelli S, Chiodi S, Costantini S, et al. Female genital tract graft-vs.-host disease following allogeneic bone marrow transplantation. Haematologica 2003;88:1163–8
   PubMed Web of Science ®Google Scholar
• Chung CP, Sargent RE, Chung NT, Lacey JV, Jr, Wakabayashi MT. Graft-vs.-host disease-associated vulvovaginal symptoms after bone marrow transplantation. Biol Blood Marrow Transplant 2016;22:378–9
   PubMed Web of Science ®Google Scholar
• Lee SJ, Vogelsang G, Gilman A, et al. A survey of diagnosis, management, and grading of chronic GVHD. Biol Blood Marrow Transplant 2002;8:32–9
   PubMed Web of Science ®Google Scholar
• Kornik RI, Rustagi AS. Vulvovaginal graft-vs.-host disease. Obstet Gynecol Clin North Am 2017;44:475–92
   PubMed Web of Science ®Google Scholar
• Hamilton BK, Goje O, Savani BN, et al. Clinical management of genital chronic GvHD. Bone Marrow Transplant 2017;52:803–10
   PubMed Web of Science ®Google Scholar
• Buchan A, Merideth MA, Childs RW, et al. Novel management of vaginal chronic graft-vs.-host disease causing haematometra and haematocolpos. BMJ Case Rep 2018
   PubMedGoogle Scholar
• Sturdee DW, Panay N. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric 2010;13:509–22
   PubMed Web of Science ®Google Scholar
• Tauchmanovà L, Selleri C, De Rosa G, et al. Gonadal status in reproductive age women after haematopoietic stem cell transplantation for haematological malignancies. Hum Reprod 2003;18:1410–16
   PubMed Web of Science ®Google Scholar
• Shanis D, Merideth M, Pulanic TK, et al. Female long-term survivors after allogeneic hematopoietic stem cell transplantation: evaluation and management. Semin Hematol 2012;49:83–93
   PubMed Web of Science ®Google Scholar
• Stratton P, Turner ML, Childs R, et al. Vulvovaginal chronic graft-vs.-host disease with allogeneic hematopoietic stem cell transplantation. Obstet Gynecol 2007;110:1041–9
   PubMed Web of Science ®Google Scholar
• Carpenter PA, Kitko CL, Elad S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-vs.-host disease: V. The 2014 ancillary therapy and supportive care working group report. Biol Blood Marrow Transplant 2015;21:1167–87
   PubMed Web of Science ®Google Scholar
• Jagasia MH, Greinix HT, Arora M, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-vs.-host disease: I. The 2014 diagnosis and staging working group report. Biol Blood Marrow Transplant 2015;21:389–401.e1
   PubMed Web of Science ®Google Scholar
• Rajkumar S, Lewis F, Nath R. The importance of topical steroids after adhesiolysis in erosive lichen planus and graft vs. host disease. J Obstet Gynaecol 2019;39:82–5
   PubMedGoogle Scholar
• Shulman HM, Cardona DM, Greenson JK, et al. NIH consensus development project on criteria for clinical trials in chronic graft-vs.-host disease: II. The 2014 pathology working group report. Biol Blood Marrow Transplant 2015;21:589–603
   PubMed Web of Science ®Google Scholar
• Savani BN, Shenoy A, Stratton P, et al. 50: increased risk of cervical dysplasia in long term survivors of allogeneic stem cell transplantation – implications for screening and HPV vaccination. Biol Blood Marrow Transplant 2008;14:(Suppl):20–1
   PubMedGoogle Scholar
• Shulman HM, Kleiner D, Lee SJ, et al. Histopathologic diagnosis of chronic graft-vs.-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-vs.-host disease: II. Pathology working group report. Biol Blood Marrow Transplant 2006;12:31–47
   PubMed Web of Science ®Google Scholar
• Frey Tirri B, Häusermann P, Bertz H, et al. Clinical guidelines for gynecologic care after hematopoietic SCT. Report from the international consensus project on clinical practice in chronic GVHD. Bone Marrow Transplant 2015;50:3–9
   PubMed Web of Science ®Google Scholar
• Humphreys CT, Tallman B, Altmaier EM, et al. Sexual functioning in patients undergoing bone marrow transplantation: a longitudinal study. Bone Marrow Transplant 2007;39:491–6
   PubMed Web of Science ®Google Scholar
• Scanlon M, Blaes A, Geller M, et al. Patient satisfaction with physician discussions of treatment impact on fertility, menopause and sexual health among pre-menopausal women with cancer. J Cancer 2012;3:217–25
   PubMed Web of Science ®Google Scholar
• Dyer G, Gilroy N, Bradford J, et al. A survey of fertility and sexual health following allogeneic haematopoietic stem cell transplantation in New South Wales, Australia. Br J Haematol 2016;172:592–601
   PubMed Web of Science ®Google Scholar
• The NAMS Hormone Therapy Position Statement Advisory Panel. The 2017 hormone therapy position statement of The North American Menopause Society. Menopause 2017;24:728–53
   PubMedGoogle Scholar
• Tedeschi SK, Savani BN, Jagasia M, et al. Time to consider HPV vaccination after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2010;16:1033–6
   PubMed Web of Science ®Google Scholar